Trial is evaluating ciforadenant as a potential first line therapy for metastatic renal cell cancer (RCC) in combination with ipilimumab (anti-CTLA-4) and nivolumab (anti-PD-1) ...

Presentations to highlight JADE101’s preclinical safety profile and translational framework guiding its clinical development in IgA nephropathyJADE101 is an investigational, potentially best-in-class ...

A presentation that has been shared with the Trump administration references Tesla, Ikea, TSMC, and more in its plan to ...

India's Rs 28,000 crore data center boom is accelerating, driven by cloud and AI growth. These 3 emerging players are poised ...

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, ...

MUMBAI, India and NAPLES, Fla. and BERLIN, Oct. 13, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) will ...

The use of cameras by law enforcement to automatically scan license plates and record vehicle information in an online ...

ANZ outlines a cost-focused strategy under new CEO Nuno Matos, with execution risks and limited innovation. Find out why ...

Kansas Legislature's committee on election transparency engages in lights-out argument about partisanship in crafting the ...

A celebrated Vancouver researcher used fabricated data and hid evidence of infected wounds to falsely claim his patented skin ...

Based on Stoke Therapeutics’ preliminary estimates, which scaled annual incidence to prevalence using country-specific live birth rates over the past 85 years and adjusted for Dravet-specific ...

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, Octobe ...